Efficacy of autologous and non-processed melanocyte grafting in treatment of vitiligo

Efficacy of autologous non-cultured and non-trypsinised melanocytes and keratinocytes grafting in treatment of refractory vitiligo

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20110507006403N9

Enrollment

Registered

2020-03-16

Start date

2020-02-19

Completion date

Unknown

Last updated

2020-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vitiligo. Vitiligo

Interventions

The epidermis is shaved from the lower limb as donor site, which has normal pigment with a disposable and sharp curettage device. The harvested materials is mixed with hyaluronic acid gel. The vitilig

Eligibility

Sex/Gender

All

Age

15 Years to 60 Years

Inclusion criteria

Inclusion criteria: Clinically documented vitiligenous lesions

Exclusion criteria

Exclusion criteria: Unstable vitiligo Pregnancy Breast feeding Generalized vitiligo Patients recently subject to phototherapy and drugs used for vitiligo Cardio-vascular patients Patients with repair disorder

Design outcomes

Primary

Measure	Time frame
Re-pigmentation. Timepoint: The first and third week and then every month for up to 4 months. Method of measurement: Area measurement with software.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Ahmad Aghaei

Kermanshah University of Medical Sciences

fatemehahmadaghaei@yahoo.com+98 83 3845 3486

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026